IP Library Granted Patent US 8,372,805
Granted Patent B1
US 8,372,805 · App. 11/894,725 · Granted Feb 12, 2013

Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,805
App. No.
11/894,725
Granted
Feb 12, 2013
Kind
B1
Abstract

Disclosed herein are improved osteogenic devices and methods of use thereof for repair of bone and cartilage defects. The devices and methods promote accelerated formation of repair tissue with enhanced stability using less osteogenic protein than devices in the art. Defects susceptible to repair with the instant invention include, but are not limited to: critical size defects, non-critical size defects, non-union fractures, fractures, osteochondral defects, subchondral defects, and defects resulting from degenerative diseases such as osteochondritis dessicans.

Claims (9)

1. A method for inducing local bone or cartilage formation, comprising the step of providing to a defect site a device comprising: (a) OP-1; (b) collagen; and (c) alkylcellulose having a viscosity of about 10-200 cP at a 4% (w/v) concentration of said alkylcellulose; wherein the ratio of said alkylcellulose to said collagen in said device is 1 part by weight alkylcellulose to 2-10 parts by weight collagen.

2. The method of claim 1 , wherein the defect site is selected from the group consisting of endochondral bone, osteochondral bone, intramembraneous bone, articular cartilage, fibrocartilage and elastic cartilage.

3. The method of claim 2 , wherein the defect site is endochondral bone or osteochondral bone.

4. The method of claim 2 , wherein the defect site is selected from the group consisting of articular cartilage, fibrocartilage and elastic cartilage.

5. The method of claim 1 , wherein the ratio of said alkylcellulose to said collagen in said device is 1 part by weight alkylcellulose to 5 parts by weight collagen.

6. The method of claim 1 or 5 , wherein said alkylcellulose is low viscosity grade carboxymethylcellulose.

7. The method of claim 6 , where said carboxymethylcellulose has a degree of substitution range from 0.65-0.90.

8. The method of claim 1 or 7 , wherein the device further comprises a wetting agent.

9. The method of claim 8 , wherein the wetting agent is saline.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2016
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 037460/0806 →
LIEN Recorded Jan 8, 2016
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 037461/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2014
From: STRYKER CORPORATION
To: MARIEL THERAPEUTICS, INC.
Reel/Frame 033535/0440 →